News

Article

Johnson & Johnson launches TECNIS Odyssey IOL in Europe, Middle East, and Canada

Key Takeaways

  • TECNIS Odyssey IOL offers enhanced contrast in low lighting and continuous vision across all distances, addressing cataract patients' need for spectacle independence.
  • The lens is part of Johnson & Johnson's advanced presbyopia correction IOL portfolio, including TECNIS PureSee, meeting diverse needs of an aging population.
SHOW MORE

(Image Credit: AdobeStock/Sundry Photography)

(Image Credit: AdobeStock/Sundry Photography)

Johnson & Johnson has launched TECNIS Odyssey IOL in Europe, the Middle East, and Canada. The TECNIS Odyssey IOL was first launched in the US in October 2024.1,2

The TECNIS Odyssey IOL is a full vision range intraocular lens (IOL), built on the TECNIS platform from Johnson & Johnson, which, according to the company,1 provides 2 times better contrast in low lighting than PanOptix. The TECNIS Odyssey combines advanced optics and proprietary materials, offering consistently clear, high-contrast vision, according to the company.

Peter Menziuso, company group chairman of Vision at Johnson & Johnson, commented on the launch in a news release from the company, saying, “TECNIS Odyssey IOL is the fastest-growing PC-IOL in the United States, and we are excited to be making it available to more patients around the world. It addresses a significant unmet need for cataract patients seeking greater spectacle independence. Now—together with TECNIS PureSee—TECNIS Odyssey IOL elevates the strength and depth of our global IOL portfolio, meeting the diverse needs of today's aging population.”

Additionally, the company says that the TECNIS Odyssey and its unique, freeform diffractive surface were designed to eliminate the gaps between near, intermediate, and far distances and offer continuous, uninterrupted vision at all distances. More than 95% of patients were satisfied with both reading on a smartphone/tablet and distance vision.

Johnson & Johnson’s portfolio of advanced presbyopia correction IOLs available in Europe, the Middle East, Canada, and Japan now includes both the TECNIS Odyssey IOL and the TECNIS PureSee IOL.

References:
  1. Johnson & Johnson launches new TECNIS Odyssey next-generation intraocular lens in Europe, the Middle East, and Canada offering cataract patients precise vision at every distance in any lighting. June 17, 2025. Accessed June 17, 2025. https://www.prnewswire.com/news-releases/johnson--johnson-launches-new-tecnis-odyssey-next-generation-intraocular-lens-in-europe-the-middle-east-and-canada-offering-cataract-patients-precise-vision-at-every-distance-in-any-lighting1-6--302483215.html
  2. Harp MD. Johnson & Johnson launches TECNIS Odyssey IOL in US. October 1, 2024. Accessed June 17, 2025. https://www.ophthalmologytimes.com/view/johnson-johnson-launches-tecnis-odyssey-iol-in-us

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting, Seth Pantanelli, MD, speaks about the EyHance and enVista IOLs. Dr. Pantanelli is a professor of ophthalmology at Penn State College of Medicine in Hershey, Pennsylvania.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.